University of Texas Health Science Center at Houston: Medication Benefits Patients With Huntington's Disease-Associated Chorea
April 13, 2022
April 13, 2022
HOUSTON, Texas, April 13 (TNSRes) -- The University of Texas Health Science Center at Houston issued the following news:
By Caitie Barkley
A new drug has proven beneficial in treating a movement disorder commonly associated with Huntington's disease, according to a recent international study led by UTHealth Houston researcher Erin Furr Stimming, MD, who served as principal investigator on behalf of the KINECT-HD Huntington Study Group.
Furr Stimming, p . . .
By Caitie Barkley
A new drug has proven beneficial in treating a movement disorder commonly associated with Huntington's disease, according to a recent international study led by UTHealth Houston researcher Erin Furr Stimming, MD, who served as principal investigator on behalf of the KINECT-HD Huntington Study Group.
Furr Stimming, p . . .